NOKOMIS, Fla.--(BUSINESS WIRE)--Rainbow Coral Corp.’s (OTCBB: RBCC) potential acquisition of emerging Nano3D Biosciences (n3D) exemplifies the company’s new approach in biotechnology investment.
In an industry in which it typically takes many years, hundreds of millions of dollars and a little luck to produce a marketable product, RBCC is exploring a new model for success—seeking out later-stage bioscience companies with whom to partner.